Brazil

  • Research and Demonstration Projects: Brazil hosted three sites in the phase III iPrEx trial, and the open label extension of iPrEx. Brazil has an ongoing PrEP demonstration project in MSM and transgender women, PrEPBrasil. A second demonstration project is scheduled to start by mid-2015 and will enroll MSM, commercial sex workers and drug users.
  • Drug Registration: Gilead submitted an application for Truvada as PrEP to Brazil’s regulatory authority in 2014. It is awaiting approval.
  • Policy/Regulatory: In May 2017, the Brazilian Ministry of Health announced that PrEP would be offered to individuals at the highest risk of HIV infection. This includes men who have sex with men, sex workers and serodiscordant couples.
  • Advocacy: If you’re a Brazilian advocate working on PrEP, building a campaign or seeking to share insights and experience, please send info here and PrEPWatch will post it.

Last updated on September 1, 2017.

News Spotlight